2014
DOI: 10.4161/adna.28422
|View full text |Cite
|
Sign up to set email alerts
|

Anomeric DNA quadruplexes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 41 publications
0
8
0
Order By: Relevance
“…A modification to the loop nucleotides in TBA may result in significantly higher nuclease resistance for the modified aptamer. For example, extraordinary nuclease resistance has been reported for anomeric modification of TBA in loop regions 23 . An increase in nuclease resistance may potentially affect the results of clotting time tests due to slower degradation of the modified TBA variants in blood plasma.…”
Section: Resultsmentioning
confidence: 99%
“…A modification to the loop nucleotides in TBA may result in significantly higher nuclease resistance for the modified aptamer. For example, extraordinary nuclease resistance has been reported for anomeric modification of TBA in loop regions 23 . An increase in nuclease resistance may potentially affect the results of clotting time tests due to slower degradation of the modified TBA variants in blood plasma.…”
Section: Resultsmentioning
confidence: 99%
“…An equally important feature, which facilitates the determination of the aptamer utility in the treatment of human diseases, is G4 thermodynamic stability. Improvement in this area was possible by the introduction of 2′-deoxy-8-bromoguanosine [44], 2′-deoxy-5-fluorouridine [38], 2′-deoxy-2′-fluoro-D-arabinonucleoside [46], unlocked nucleic acid monomer [39,40], 4-thiouridine [40], 2′,3′-seco-4-thiouridine [40], 2′-C-piperazino-unlocked nucleic acid monomer [49], 5′-5′ inversion of polarity sites [50,51], 5-bromo-2′-deoxyuridine [52], a C3 spacer [43], and anomeric α-nucleotides [53]. The most significant inconvenience of the therapeutic use of TBA is its high susceptibility to nuclease degradation in a biological environment.…”
Section: Anticoagulant Agentsmentioning
confidence: 99%
“…The most significant inconvenience of the therapeutic use of TBA is its high susceptibility to nuclease degradation in a biological environment. This problem can be solved inter alia by the inversion of polarity sites at the terminal sequence [54], covalent ligation of the 5′ and 3′ ends of TBA [55], or the introduction of anomeric α-nucleotides [53].…”
Section: Anticoagulant Agentsmentioning
confidence: 99%
“…The anticoagulant properties of the chimeric aptamers were retained only with intact TT loops. On the contrary, modification of the TGT loop only substantially increased the nuclease resistance of the chimeric aptamer without notable disturbance of its anticoagulant activity [ 178 ].…”
Section: Stabilization or Destabilization Of A Gq By The Same Syntmentioning
confidence: 99%